Tharimmune Statistics
Total Valuation
Tharimmune has a market cap or net worth of $4.35 million. The enterprise value is -$6.59 million.
Market Cap | 4.35M |
Enterprise Value | -6.59M |
Important Dates
The next estimated earnings date is Monday, May 20, 2024, before market open.
Earnings Date | May 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Tharimmune has 11.74 million shares outstanding. The number of shares has increased by 188.38% in one year.
Shares Outstanding | 11.74M |
Shares Change (YoY) | +188.38% |
Shares Change (QoQ) | +88.71% |
Owned by Insiders (%) | 8.40% |
Owned by Institutions (%) | 10.30% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.48 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.03, with zero debt.
Current Ratio | 6.03 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -563.62 |
Financial Efficiency
Return on equity (ROE) is -217.30% and return on invested capital (ROIC) is -103.55%.
Return on Equity (ROE) | -217.30% |
Return on Assets (ROA) | -159.10% |
Return on Capital (ROIC) | -103.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.66M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.23% in the last 52 weeks. The beta is 1.66, so Tharimmune's price volatility has been higher than the market average.
Beta (1Y) | 1.66 |
52-Week Price Change | -98.23% |
50-Day Moving Average | 0.40 |
200-Day Moving Average | 3.30 |
Relative Strength Index (RSI) | 38.35 |
Average Volume (30 Days) | 501,706 |
Short Selling Information
The latest short interest is 75,343, so 0.64% of the outstanding shares have been sold short.
Short Interest | 75,343 |
Short Previous Month | 22,775 |
Short % of Shares Out | 0.64% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.04 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -9.46M |
Pretax Income | -9.32M |
Net Income | -9.32M |
EBITDA | -9.30M |
EBIT | -9.30M |
Earnings Per Share (EPS) | -$7.14 |
Balance Sheet
The company has $10.94 million in cash and no debt, giving a net cash position of $10.94 million or $0.93 per share.
Cash & Cash Equivalents | 10.94M |
Total Debt | n/a |
Net Cash | 10.94M |
Net Cash Per Share | $0.93 |
Equity / Book Value | 9.13M |
Book Value Per Share | 0.78 |
Working Capital | 9.13M |
Cash Flow
Operating Cash Flow | -7.30M |
Capital Expenditures | n/a |
Free Cash Flow | -7.30M |
FCF Per Share | -$5.59 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Tharimmune does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -188.38% |
Shareholder Yield | -188.38% |
Earnings Yield | -214.31% |
FCF Yield | -167.88% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 21, 2023. It was a reverse split with a ratio of 1:25.
Last Split Date | Nov 21, 2023 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |